These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29284387)

  • 1. Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.
    Iida Y; Sawa S; Shimizu H
    Curr Drug Targets; 2018; 19(11):1297-1301. PubMed ID: 29284387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of abdominal aortic aneurysm.
    Miyake T; Morishita R
    Cardiovasc Res; 2009 Aug; 83(3):436-43. PubMed ID: 19454489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic and Therapeutic Significance of Angiotensin II Type I Receptor in Abdominal Aortic Aneurysms.
    Xu B; Xuan H; Iida Y; Miyata M; Dalman RL
    Curr Drug Targets; 2018; 19(11):1318-1326. PubMed ID: 29359665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth.
    Yu J; Liu S; Huang J; Wang W
    Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.
    Fraga-Silva RA; Trachet B; Stergiopulos N
    Curr Pharm Des; 2015; 21(28):4000-6. PubMed ID: 26306842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pharmacological approaches in abdominal aortic aneurysm.
    Puertas-Umbert L; Almendra-Pegueros R; Jiménez-Altayó F; Sirvent M; Galán M; Martínez-González J; Rodríguez C
    Clin Sci (Lond); 2023 Aug; 137(15):1167-1194. PubMed ID: 37559446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice.
    Xie X; Lu H; Moorleghen JJ; Howatt DA; Rateri DL; Cassis LA; Daugherty A
    PLoS One; 2012; 7(9):e46411. PubMed ID: 23029514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening aortic drug treatments through arterial compliance measurements.
    Rentschler ME; Baxter BT
    Curr Vasc Pharmacol; 2008 Oct; 6(4):250-7. PubMed ID: 18855713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update.
    Wang YD; Liu ZJ; Ren J; Xiang MX
    Curr Vasc Pharmacol; 2018 Jan; 16(2):114-124. PubMed ID: 28412911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth predictors and prognosis of small abdominal aortic aneurysms.
    Schlösser FJ; Tangelder MJ; Verhagen HJ; van der Heijden GJ; Muhs BE; van der Graaf Y; Moll FL;
    J Vasc Surg; 2008 Jun; 47(6):1127-33. PubMed ID: 18440183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.
    Yoshimura K; Morikage N; Nishino-Fujimoto S; Furutani A; Shirasawa B; Hamano K
    Curr Drug Targets; 2018; 19(11):1265-1275. PubMed ID: 29284386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of an effective drug therapy for abdominal aortic aneurysm.
    Golledge J; Moxon JV; Singh TP; Bown MJ; Mani K; Wanhainen A
    J Intern Med; 2020 Jul; 288(1):6-22. PubMed ID: 31278799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms.
    Katz DA; Cronenwett JL
    J Vasc Surg; 1994 Jun; 19(6):980-90; discussion 990-1. PubMed ID: 8201717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aortic neck dilation and elongation in the etiology of stent graft migration after endovascular abdominal aortic aneurysm repair with a passive fixation device.
    Litwinski RA; Donayre CE; Chow SL; Song TK; Kopchok G; Walot I; White RA
    J Vasc Surg; 2006 Dec; 44(6):1176-81. PubMed ID: 17145418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.
    Aoki H; Yoshimura K; Matsuzaki M
    J Mol Med (Berl); 2007 Oct; 85(10):1077-88. PubMed ID: 17522832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2.
    Moran CS; Biros E; Krishna SM; Wang Y; Tikellis C; Morton SK; Moxon JV; Cooper ME; Norman PE; Burrell LM; Thomas MC; Golledge J
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2195-2203. PubMed ID: 28935757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of abdominal aortic aneurysm.
    Golledge J; Powell JT
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):267-73. PubMed ID: 17540588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aorto-caval fistula due to abdominal aortic aneurysm rupture].
    Davidović L; Petrović P; Lotina S; Colić M; Vukotić A; Nesković AN
    Srp Arh Celok Lek; 1997; 125(11-12):370-4. PubMed ID: 9480573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
    Thompson RW; Baxter BT
    Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of abdominal aortic aneurysms.
    Weiss N; Rodionov RN; Mahlmann A
    Vasa; 2014 Nov; 43(6):415-21. PubMed ID: 25339159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.